Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-α
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-α
Authors
Keywords
-
Journal
eLife
Volume 9, Issue -, Pages -
Publisher
eLife Sciences Publications, Ltd
Online
2020-02-24
DOI
10.7554/elife.52668
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PD-1/PD-L1 Pathway Modulates Macrophage Susceptibility to Mycobacterium tuberculosis Specific CD8+ T cell Induced Death
- (2019) Guadalupe Verónica Suarez et al. Scientific Reports
- In Vitro Granuloma Models of Tuberculosis: Potential and Challenges
- (2019) Paul Elkington et al. JOURNAL OF INFECTIOUS DISEASES
- Invariant Natural Killer T-cell Dynamics in Human Immunodeficiency Virus–associated Tuberculosis
- (2019) Naomi F Walker et al. CLINICAL INFECTIOUS DISEASES
- Tuberculosis Infection in a Patient Treated With Nivolumab for Non-small Cell Lung Cancer: Case Report and Literature Review
- (2019) Ronwyn van Eeden et al. Frontiers in Oncology
- TNF Induces Pathogenic Programmed Macrophage Necrosis in Tuberculosis through a Mitochondrial-Lysosomal-Endoplasmic Reticulum Circuit
- (2019) Francisco J. Roca et al. CELL
- The molecular clock of Mycobacterium tuberculosis
- (2019) Fabrizio Menardo et al. PLoS Pathogens
- Development of pulmonary tuberculosis following treatment with anti-PD-1 for non-small cell lung cancer
- (2018) Kristian Hastoft Jensen et al. ACTA ONCOLOGICA
- Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment
- (2018) H. Picchi et al. CLINICAL MICROBIOLOGY AND INFECTION
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Implications of Tuberculosis Reactivation after Immune Checkpoint Inhibition
- (2018) Paul T Elkington et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Paradoxical response in a patient with non-small cell lung cancer who received nivolumab followed by anti- Mycobacterium tuberculosis agents
- (2018) So Takata et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- PD-1 Expression on Mycobacterium tuberculosis-Specific CD4 T Cells Is Associated With Bacterial Load in Human Tuberculosis
- (2018) Cheryl L. Day et al. Frontiers in Immunology
- Antibodies to watch in 2019
- (2018) Hélène Kaplon et al. mAbs
- Re-activation of pulmonary tuberculosis during anti-programmed death-1 (PD-1) treatment
- (2018) C -C Tsai et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Activated pulmonary tuberculosis in a patient with melanoma during PD-1 inhibition: a case report
- (2018) Wan He et al. OncoTargets and Therapy
- Beyond Killing Mycobacterium tuberculosis: Disease Tolerance
- (2018) Maziar Divangahi et al. Frontiers in Immunology
- Phenolic Glycolipid Facilitates Mycobacterial Escape from Microbicidal Tissue-Resident Macrophages
- (2017) C.J. Cambier et al. IMMUNITY
- Mycobacterium tuberculosisreplicates within necrotic human macrophages
- (2017) Thomas R. Lerner et al. JOURNAL OF CELL BIOLOGY
- Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Death-Ligand 1 (PD-1/PD-L1) Interaction via Transiently Induced Protein States and Dimerization of PD-L1
- (2017) Katarzyna Guzik et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pericardial Tamponade Caused by a Hypersensitivity Response to Tuberculosis Reactivation after Anti–PD-1 Treatment in a Patient with Advanced Pulmonary Adenocarcinoma
- (2017) Yi-Chun Chu et al. Journal of Thoracic Oncology
- Dissection of the host-pathogen interaction in human tuberculosis using a bioengineered 3-dimensional model
- (2017) Liku B Tezera et al. eLife
- Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis
- (2017) Bibhuti B. Mishra et al. Nature Microbiology
- Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin’s lymphoma
- (2016) Joycelyn J. X. Lee et al. ACTA ONCOLOGICA
- Macrophage Epithelial Reprogramming Underlies Mycobacterial Granuloma Formation and Promotes Infection
- (2016) Mark R. Cronan et al. IMMUNITY
- Anti-PD1 Antibody Treatment and the Development of Acute Pulmonary Tuberculosis
- (2016) Kohei Fujita et al. Journal of Thoracic Oncology
- Host-directed therapies for infectious diseases: current status, recent progress, and future prospects
- (2016) Alimuddin Zumla et al. LANCET INFECTIOUS DISEASES
- Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers
- (2016) Robert S Wallis et al. LANCET INFECTIOUS DISEASES
- Hypoxia and tissue destruction in pulmonary TB
- (2016) Moerida Belton et al. THORAX
- Tuberculosis: An Infection-Initiated Autoimmune Disease?
- (2016) Paul Elkington et al. TRENDS IN IMMUNOLOGY
- CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease
- (2016) Shunsuke Sakai et al. PLoS Pathogens
- Proteomics Analysis of Three Different Strains of Mycobacterium tuberculosis under In vitro Hypoxia and Evaluation of Hypoxia Associated Antigen’s Specific Memory T Cells in Healthy Household Contacts
- (2016) Santhi Devasundaram et al. Frontiers in Microbiology
- PD-1/PD-L pathway inhibits M.tb-specific CD4+ T-cell functions and phagocytosis of macrophages in active tuberculosis
- (2016) Lei Shen et al. Scientific Reports
- Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis
- (2015) Marc Tebruegge et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Extracellular Matrix Regulates Granuloma Necrosis in Tuberculosis
- (2015) Basim Al Shammari et al. JOURNAL OF INFECTIOUS DISEASES
- Permutations of time and place in tuberculosis
- (2015) Paul T Elkington et al. LANCET INFECTIOUS DISEASES
- MAIT Cell Function is Modulated by PD-1 Signaling in Patients with Active Tuberculosis
- (2014) Jing Jiang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Programmed Death (PD)-1:PD-Ligand 1/PD-Ligand 2 Pathway Inhibits T Cell Effector Functions during Human Tuberculosis
- (2014) J. O. Jurado et al. JOURNAL OF IMMUNOLOGY
- Mycobacterium tuberculosis Ser/Thr Protein Kinase B Mediates an Oxygen-Dependent Replication Switch
- (2014) Corrie Ortega et al. PLOS BIOLOGY
- iNKT Cell Production of GM-CSF Controls Mycobacterium tuberculosis
- (2014) Alissa C. Rothchild et al. PLoS Pathogens
- The Immune Response in Tuberculosis
- (2013) Anne O'Garra et al. Annual Review of Immunology
- TNF Dually Mediates Resistance and Susceptibility to Mycobacteria via Mitochondrial Reactive Oxygen Species
- (2013) Francisco J. Roca et al. CELL
- Inhibiting the Programmed Death 1 Pathway Rescues Mycobacterium tuberculosis–Specific Interferon γ–Producing T Cells From Apoptosis in Patients With Pulmonary Tuberculosis
- (2013) Amar Singh et al. JOURNAL OF INFECTIOUS DISEASES
- Multifunctional essentiality of succinate metabolism in adaptation to hypoxia in Mycobacterium tuberculosis
- (2013) H. Eoh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease
- (2011) Alexandre Harari et al. NATURE MEDICINE
- Tuberculosis Immunopathology: The Neglected Role of Extracellular Matrix Destruction
- (2011) P. T. Elkington et al. Science Translational Medicine
- CD4 T Cells Promote Rather than Control Tuberculosis in the Absence of PD-1-Mediated Inhibition
- (2010) D. L. Barber et al. JOURNAL OF IMMUNOLOGY
- Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis
- (2010) E. Lazar-Molnar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor Necrosis Factor Signaling Mediates Resistance to Mycobacteria by Inhibiting Bacterial Growth and Macrophage Death
- (2008) Hilary Clay et al. IMMUNITY
- Macrophage and T Cell Dynamics during the Development and Disintegration of Mycobacterial Granulomas
- (2008) Jackson G. Egen et al. IMMUNITY
- Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates
- (2008) L. E. Via et al. INFECTION AND IMMUNITY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started